Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics

被引：0

作者：

Jang, Hyemin ^{[1
]}

Shin, Daeun ^{[2
]}

Yoo, Heejin ^{[2
]}

Zetterberg, Henrik ^{[3
,4
,5
,6
,7
,8
]}

Blennow, Kaj ^{[3
,4
,9
,10
,11
,12
]}

Gonzalez-Ortiz, Fernando ^{[3
,4
]}

Ashton, Nicholas J. ^{[3
,13
,14
,15
,16
]}

Day, Theresa A. ^{[17
]}

Lee, Eun Hye ^{[2
]}

Yun, Jihwan ^{[18
]}

Na, Duk L. ^{[2
]}

Kim, Hee Jin ^{[2
,19
,20
,21
]}

Kang, Sung Hoon ^{[22
]}

Kim, Ko Woon ^{[23
]}

Kim, Si Eun ^{[24
]}

Kim, Yeo Jin ^{[25
]}

Kim, Yeshin ^{[26
]}

Kim, Jaeho ^{[27
]}

Kim, Chi-Hun ^{[28
]}

Chun, Min Young ^{[29
,30
]}

Jung, Na Yeon ^{[31
]}

Cho, Soo Hyun ^{[32
]}

Kim, Jun Pyo ^{[2
]}

Seo, Sang Won ^{[2
,19
,20
,21
]}

K-ROAD Study Grp

机构：

[1] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul Natl Univ Hosp, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea

[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden

[4] Sahlgrens Univ Hosp, Clin Neurochem Lab, Gothenburg, Sweden

[5] UCL, Dept Neurodegenerat Dis, Inst Neurol, Queen Sq, London, England

[6] UCL, UK Dementia Res Inst, London, England

[7] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China

[8] Univ Wisconsin Madison, Wisconsin Alzheimers Dis Res Ctr, Univ Wisconsin Sch Med & Publ Hlth, Madison, WI USA

[9] Sorbonne Univ, Pitie Salpetriere Hosp, Paris Brain Inst, ICM, Paris, France

[10] Univ Sci & Technol China, Affiliated Hosp USTC 1, Inst Aging & Brain Disorders, Hefei, Peoples R China

[11] Univ Sci & Technol China, Inst Aging & Brain Disorders, Dept Neurol, Hefei, Peoples R China

[12] USTC, Affiliated Hosp 1, Hefei, Peoples R China

[13] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, De Crespigny Pk, London, England

[14] South London & Maudsley NHS Fdn Trust, NIHR Biomed Res Ctr Mental Hlth, De Crespigny Pk, London, England

[15] South London & Maudsley NHS Fdn, Biomed Res Unit Dementia, De Crespigny Pk, London, England

[16] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway

[17] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN USA

[18] Soonchunhyang Univ, Bucheon Hosp, Dept Neurol, Bucheon Si, Gyeonggi Do, South Korea

[19] Samsung Med Ctr, Alzheimers Dis Convergence Res Ctr, Seoul, South Korea

[20] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea

[21] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea

[22] Korea Univ, Coll Med, Dept Neurol, Guro Hosp, Seoul, South Korea

[23] Jeonbuk Natl Univ, Med Sch & Hosp, Dept Neurol, Jeonju Si, South Korea

[24] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Neurol, Busan, South Korea

[25] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Neurol, Seoul, South Korea

[26] Kangwon Natl Univ, Sch Med, Kangwon Natl Univ Hosp, Dept Neurol, Chuncheon Si, Gangwon Do, South Korea

[27] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Seoul, South Korea

[28] Hallym Univ, Coll Med, Dept Neurol, Sacred Heart Hosp, Anyang Si 431070, Gyeonggi Do, South Korea

[29] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea

[30] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Neurol, Yongin, Gyeonggi Do, South Korea

[31] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan Si, Gyeongsangnam D, South Korea

[32] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea

来源：

ALZHEIMERS & DEMENTIA | 2025年 / 21卷 / 02期

基金：

瑞典研究理事会; 新加坡国家研究基金会;

关键词：

Alzheimer's disease; neurofilament light chain; positron emission tomography; plasma biomarker; p-tau217; PHOSPHORYLATED TAU 181; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; PROTEIN;

D O I：

10.1002/alz.14526

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

INTRODUCTION This study aimed to investigate the differential roles of various plasma biomarkers in a stepwise diagnostic strategy for Alzheimer's disease (AD). METHODS A total of 2984 participants, including 666 cognitively unimpaired (CU), 2032 with Alzheimer's clinical syndrome (ACS), and 286 non-ACS individuals, were recruited. Plasma amyloid beta (A beta) 42/40, four phosphorylated tau (p-tau) epitopes, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels were measured using immunoassays. RESULTS NfL demonstrated fair to excellent accuracy in differentiating non-ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p-tau217 had the highest accuracy for identifying A beta (AUC 0.94) and tau positron emission tomography status (AUC 0.91). In the ACS group, p-tau217 was the strongest predictor of cognitive decline (p < .001). DISCUSSION NfL may serve as a useful screening tool, while p-tau217 is particularly valuable for confirming AD pathology and prognosis.

引用

页数：12

共 50 条

[21] Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis
Pena-Bautista, Carmen
Alvarez, Lourdes
Durand, Thierry
Vigor, Claire
Cuevas, Ana
Baquero, Miguel
Vento, Maximo
Hervas, David
Chafer-Pericas, Consuelo
ANTIOXIDANTS, 2020, 9 (08) : 1 - 12
[22] Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Hampel, Harald
Toschi, Nicola
Baldacci, Filippo
Zetterberg, Henrik
Blennow, Kaj
Kilimann, Ingo
Teipel, Stefan J.
Cavedo, Enrica
dos Santos, Antonio Melo
Epelbaum, Stephane
Lamari, Foudil
Genthon, Remy
Dubois, Bruno
Floris, Roberto
Garaci, Francesco
Lista, Simone
ALZHEIMERS & DEMENTIA, 2018, 14 (04) : 492 - 501
[23] Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease
Lewczuk, Piotr
Ermann, Natalia
Andreasson, Ulf
Schultheis, Christian
Podhorna, Jana
Spitzer, Philipp
Maler, Juan Manuel
Kornhuber, Johannes
Blennow, Kaj
Zetterberg, Henrik
ALZHEIMERS RESEARCH & THERAPY, 2018, 10
[24] Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Piotr Lewczuk
Natalia Ermann
Ulf Andreasson
Christian Schultheis
Jana Podhorna
Philipp Spitzer
Juan Manuel Maler
Johannes Kornhuber
Kaj Blennow
Henrik Zetterberg
Alzheimer's Research & Therapy, 10
[25] Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases
Campese, Nicole
Beatino, Maria Francesca
Del Gamba, Claudia
Belli, Elisabetta
Giampietri, Linda
Del Prete, Eleonora
Galgani, Alessandro
Vergallo, Andrea
Siciliano, Gabriele
Ceravolo, Roberto
Hampel, Harald
Baldacci, Filippo
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (09) : 949 - 967
[26] Biomarkers of synaptic degeneration in Alzheimer's disease
Cheng, Qian
Fan, Yiou
Zhang, Pengfei
Liu, Huan
Han, Jialin
Yu, Qian
Wang, Xueying
Wu, Shuang
Lu, Zhiming
AGEING RESEARCH REVIEWS, 2025, 104
[27] Biomarkers in Alzheimer's disease
Janeiro, Manuel H.
Ardanaz, Carlos G.
Sola-Sevilla, Noemi
Dong, Jinya
Cortes-Erice, Maria
Solas, Maite
Puerta, Elena
Ramirez, Maria J.
ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2021, 2 (01): : 27 - 37
[28] Biomarkers of Alzheimer's disease
Craig-Schapiro, Rebecca
Fagan, Anne M.
Holtzman, David M.
NEUROBIOLOGY OF DISEASE, 2009, 35 (02) : 128 - 140
[29] Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes
Pena-Bautista, Carmen
Ferre-Gonzalez, Laura
Cubas, Laura
Balaguer, Angel
Casanova-Estruch, Bonaventura
Baquero, Miguel
Chafer-Pericas, Consuelo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
[30] Plasma biomarkers and their correlation in adult children of parents with Alzheimer's disease
Huang, Ling-Chun
Chen, Ming-Hui
Chuu, Chih-Pin
Li, Kuan-Ying
Hour, Tzyh-Chyuan
Yang, Yuan-Han
FRONTIERS IN AGING NEUROSCIENCE, 2022, 14

← 1 2 3 4 5 →